32 related articles for article (PubMed ID: 31892575)
1. Prognostic value of PD-L1 expression in combination with CD8
Yang H; Shi J; Lin D; Li X; Zhao C; Wang Q; Zhang L; Jiang T; Zhao S; Liu X; Jia Y; Zhang Y; Cai W; Zhou C
Cancer Med; 2018 Jan; 7(1):32-45. PubMed ID: 29168339
[TBL] [Abstract][Full Text] [Related]
2. CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis.
Fu M; Feng C; Wang J; Guo C; Wang Y; Gao R; Wang J; Zhu Q; Zhang X; Qi J; Zhang Y; Bian Y; Wang Z; Fang Y; Cao L; Hong B; Wang H
Clin Exp Med; 2024 May; 24(1):99. PubMed ID: 38748269
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.
Ueno T; Tsuchikawa T; Hatanaka KC; Hatanaka Y; Mitsuhashi T; Nakanishi Y; Noji T; Nakamura T; Okamura K; Matsuno Y; Hirano S
Oncotarget; 2018 Apr; 9(28):20034-20047. PubMed ID: 29732001
[TBL] [Abstract][Full Text] [Related]
4. The Balance of CD8-Positive T Cells and PD-L1 Expression in the Myocardium Predicts Prognosis in Lymphocytic Fulminant Myocarditis.
Hiraiwa H; Morimoto R; Tsuyuki Y; Ushida K; Ito R; Kazama S; Kimura Y; Araki T; Mizutani T; Oishi H; Kuwayama T; Kondo T; Okumura T; Murohara T
Cardiology; 2024; 149(1):28-39. PubMed ID: 37827123
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma.
Okuda K; Oda R; Suzuki A; Sakane T; Kawano O; Haneda H; Moriyama S; Nakanishi R
J Thorac Dis; 2017 May; 9(5):1295-1302. PubMed ID: 28616281
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary pleomorphic carcinoma presenting as undifferentiated non-small cell carcinoma with giant cells: A case report and review of literature.
Jeong JH; Seo HJ; Yoon SH; Hong R
Respir Med Case Rep; 2020; 31():101225. PubMed ID: 33005565
[TBL] [Abstract][Full Text] [Related]
7. Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung.
Roma L; Ercan C; Conticelli F; Akyürek N; Savic Prince S; Mertz KD; Diebold J; Lardinois D; Piscuoglio S; Ng CK; Bubendorf L
J Thorac Oncol; 2024 May; ():. PubMed ID: 38723776
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.
Imai H; Kaira K; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Kosaka T; Yajima T; Ohtaki Y; Osaki T; Kogure Y; Tanaka S; Fujita A; Oyama T; Minato K; Asao T; Shirabe K
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32028659
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary pleomorphic carcinoma treated with PD-1 inhibitor: Two case reports.
Jiang T; Wang H; Xue F; Wu X; Ni M; Wang Y; Chen N; Zhang Y; Zhang G; Fu J; Liu X; Wu Q
Thorac Cancer; 2023 Nov; 14(32):3240-3244. PubMed ID: 37779217
[TBL] [Abstract][Full Text] [Related]
10. Persistent fecal occult blood due to the small intestinal metastasis of pleomorphic lung carcinoma.
Suzuki T; Noda M; Yamamura A; Ohishi H; Notsuda H; Eba S; Tanaka R; Tanaka N; Kamei T; Unno M; Okada Y
J Surg Case Rep; 2022 Feb; 2022(2):rjac043. PubMed ID: 35198146
[TBL] [Abstract][Full Text] [Related]
11. Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pleomorphic Carcinoma of the Lung.
Okauchi S; Sasatani Y; Shiozawa T; Yamada H; Miyazaki K; Takayashiki N; Satoh H
In Vivo; 2020; 34(3):1439-1443. PubMed ID: 32354943
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
Hu C; Tian S; Lin L; Zhang J; Ding H
Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
[TBL] [Abstract][Full Text] [Related]
13. Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.
Imanishi N; Hirai A; Yoneda K; Shimajiri S; Kuwata T; Tashima Y; Takeuchi M; Iwai Y; Ichiki Y; Tanaka F
J Surg Oncol; 2018 Jun; 117(7):1563-1569. PubMed ID: 29601633
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
15. High programmed death ligand 1 expression in carcinomatous components predicts a poor prognosis in pulmonary pleomorphic carcinoma.
Noguchi M; Menju T; Nakajima N; Yoshizawa A; Ohsumi A; Nakajima D; Hamaji M; Haga H; Date H
Surg Today; 2022 Jul; 52(7):1090-1095. PubMed ID: 35041089
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients.
Chen JG; Xia JC; Liang XT; Pan K; Wang W; Lv L; Zhao JJ; Wang QJ; Li YQ; Chen SP; He J; Huang LX; Ke ML; Chen YB; Ma HQ; Zeng ZW; Zhou ZW; Chang AE; Li Q
Int J Biol Sci; 2011 Jan; 7(1):53-60. PubMed ID: 21234303
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Tumor Immunity in Surgically Resected Pulmonary Pleomorphic Carcinoma.
Kaira K; Shimizu K; Endoh H; Imaizumi K; Kamiyoshihara M; Sugano M; Kawashima O; Tanaka S; Fujita A; Imai H; Kogure Y; Oyama T; Asao T; Shirabe K
Anticancer Res; 2020 Jan; 40(1):261-269. PubMed ID: 31892575
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
